Stockreport

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

Kodiak Sciences Inc  (KOD) 
Last kodiak sciences inc earnings: 11/12 05:30 am Check Earnings Report
PDF Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026.GLOW2 study design mirrors GLOW1 study, which met primary endpoint and all key s [Read more]